Sage Therapeutics Stock Rockets on Two Positive Phase III Trials in Postpartum Depression Post author:Sam Post published:November 8, 2017 Post category:BioPharma The positive results support the company’s planned regulatory submissions. Source: BioSpace You Might Also Like Pfizer Quietly Kills 3 Pipeline Programs January 30, 2017 3D-Printed Patch Can Help Mend A 'Broken' Heart, University of Minnesota Study Reveals April 16, 2017 Opening Of Digital Innovation Lab Underscores Syngenta AG Commitment To Innovation May 16, 2017
3D-Printed Patch Can Help Mend A 'Broken' Heart, University of Minnesota Study Reveals April 16, 2017
